发明授权
- 专利标题： Compound
- 专利标题（中）： 复合
-
申请号： US13546444申请日： 2012-07-11
-
公开(公告)号： US08735413B2公开(公告)日： 2014-05-27
- 发明人: Stephen Connolly , Mark Richard Ebden , Iain Alastair Stewart Walters , Thomas Langer , Alan Robert Steven , Craig Robert Stewart , Paula Margaret Tomlin , Andrew John Williams
- 申请人： Stephen Connolly , Mark Richard Ebden , Iain Alastair Stewart Walters , Thomas Langer , Alan Robert Steven , Craig Robert Stewart , Paula Margaret Tomlin , Andrew John Williams
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 代理机构： Morgan, Lewis & Bockius LLP
- 主分类号： A01N43/54
- IPC分类号： A01N43/54 ; A61K31/505 ; A61K31/506 ; C07D239/56
摘要：
There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
公开/授权文献
- US20130040926A1 NOVEL COMPOUND 公开/授权日：2013-02-14
信息查询
IPC分类:
